NICE guidance (NG238) recommends that adults with a 10-year cardiovascular risk of 10% or greater should be offered statin therapy, typically atorvastatin 20 mg daily as first-line treatment
In the Heart: GLP-1 receptors were found in human and animal (mouse) cardiac tissue,In the human coronary artery endothelial cells (HCAEC) and in human umbilical vein endothelial cells (HUVEC)
For me, its never been about quick results, its about supporting your body long-term
Examples of synthetic GLP-1 are Semaglutide (ozempic, wegovy) which last 1 week, Liraglutide (Victoza, Saxenda) which last 24 hours, Tirzepatide (Mounjaro, Zepbound) which last 1 week and also targets GIP, and finally Exenatide (Byetta, Bydurette) which can last hours to a day
For specific guidance, see alcohol and semaglutide and alcohol and tirzepatide
Key risk factors include: History of Gallstones: These can obstruct the pancreatic duct, leading to inflammation